10-KPeriod: FY2020

AXON ENTERPRISE, INC. Annual Report, Year Ended Dec 31, 2020

Filed February 26, 2021For Securities:AXON

Summary

Axon Enterprise, Inc. demonstrated robust revenue growth in 2020, with net sales increasing by 28.2% to $681.0 million, driven by strong performance in both its TASER and Software & Sensors segments. The company continues its strategic shift towards recurring revenue through its cloud-based Software as a Service (SaaS) offerings, which saw a significant increase in Axon Evidence and cloud services revenue. While the company experienced an operating loss of $14.2 million, largely due to increased stock-based compensation and legal expenses, its gross margin improved to 61.1% from 57.9% in the prior year, indicating growing profitability on its core products and services. Looking ahead, Axon provided a positive outlook for 2021, projecting revenue between $740 million and $780 million, and detailed significant capital expenditures planned for capacity expansion and a new manufacturing facility. The company's strong liquidity position and strategic focus on innovation and recurring revenue streams position it well for continued growth in the public safety technology market.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by 28.2% to $681.0 million in 2020, reflecting strong demand across both TASER and Software & Sensors segments.
  • 2Gross margin improved to 61.1% in 2020 from 57.9% in 2019, driven by increased revenue and improved cost efficiencies.
  • 3The Software and Sensors segment, particularly Axon Evidence and cloud services, showed significant revenue growth, highlighting the company's successful transition to recurring revenue models.
  • 4The company ended 2020 with a substantial backlog of $1.5 billion, primarily in the Software and Sensors segment, indicating strong future revenue potential.
  • 5Axon reported $155.4 million in cash and cash equivalents and $652.6 million in total cash and investments at year-end 2020, demonstrating a healthy liquidity position.
  • 6The company forecasts 2021 revenue between $740 million and $780 million, signaling continued strong growth expectations.
  • 7Significant investments are planned for 2021, including capacity expansion for TASER devices and a new manufacturing/office facility, underscoring commitment to future growth and operational efficiency.

Frequently Asked Questions

Axon's revenue growth in 2020 was primarily driven by strong sales in its TASER segment, particularly the TASER 7 device and cartridges, and significant growth in its Software & Sensors segment, notably from Axon Evidence and cloud services. This indicates successful adoption of both its hardware and recurring software solutions.

While Axon reported an operating loss of $14.2 million in 2020, this was largely due to increases in stock-based compensation and legal expenses. However, the company's gross margin improved to 61.1%, demonstrating improved profitability on its products and services. The shift towards higher-margin recurring revenue from software and cloud services is a key factor contributing to this margin expansion.

Axon provided a positive outlook for 2021, expecting revenue to be in the range of $740 million to $780 million. The company also plans significant capital expenditures to support capacity expansion and its new manufacturing facility, reflecting confidence in continued business growth.

Key risks include continued reliance on the TASER product line, potential delays or failures in developing and launching new products, competition, supply chain disruptions (as amplified by the pandemic), government regulations, potential personal injury/wrongful death claims related to product use, and risks associated with international operations and data privacy. The company also noted the increasing shift to subscription models can impact cash collection timing.